Cloning of the gene coding for a shared human melanoma antigen recognized by autologous T cells infiltrating into tumor.
- 26 April 1994
- journal article
- Published by Proceedings of the National Academy of Sciences in Proceedings of the National Academy of Sciences
- Vol. 91 (9) , 3515-3519
- https://doi.org/10.1073/pnas.91.9.3515
Abstract
By cDNA expression cloning we have isolated a gene encoding a shared human melanoma antigen recognized by HLA-A2 restricted autologous and allogenic tumor-infiltrating lymphocytes (TILs) from patients with metastatic melanoma. By using both transient and stable expression systems, transfection of this gene into non-antigen-expressing HLA-A2+ cell lines resulted in recognition by the antigen-specific TILs. The sequence of this cDNA revealed a previously undescribed putative transmembrane protein whose expression was restricted to melanoma and melanocyte cell lines and human retina but no other fresh or cultured normal tissues tested or other tumor histologies. Thus, we have identified a gene encoding a melanocyte lineage-specific protein (MART-1; melanoma antigen recognized by T cells 1) that is a widely shared melanoma antigen recognized by the T lymphocytes of patients with established malignancy. Identification of this gene opens possibilities for the development of immunotherapies for patients with melanoma.Keywords
This publication has 35 references indexed in Scilit:
- T-Cell Recognition of Human Melanoma AntigensJournal of Immunotherapy, 1993
- Tumor-specific cytolysis by lymphocytes infiltrating human melanomas.The Journal of Immunology, 1989
- The role of HLA class I antigens in recognition of melanoma cells by tumor-specific cytotoxic T lymphocytes. Evidence for shared tumor antigens.The Journal of Immunology, 1989
- Cytolytic T-cell clones against an autologous human melanoma: specificity study and definition of three antigens by immunoselection.Proceedings of the National Academy of Sciences, 1989
- Use of Tumor-Infiltrating Lymphocytes and Interleukin-2 in the Immunotherapy of Patients with Metastatic MelanomaNew England Journal of Medicine, 1988
- Interleukin 4 promotes the growth of tumor-infiltrating lymphocytes cytotoxic for human autologous melanoma.The Journal of Experimental Medicine, 1988
- Molecular cloning of the CD2 antigen, the T-cell erythrocyte receptor, by a rapid immunoselection procedure.Proceedings of the National Academy of Sciences, 1987
- Identification of specific cytolytic immune responses against autologous tumor in humans bearing malignant melanoma.The Journal of Immunology, 1987
- A New Approach to the Adoptive Immunotherapy of Cancer with Tumor-Infiltrating LymphocytesScience, 1986
- Vitiligo in patients with metastatic melanoma: A good prognostic signJournal of the American Academy of Dermatology, 1983